I. Browne et al., PREJUNCTIONAL ACTIONS OF N-ETHYL-MALEIMIDE AND PHENOXYBENZAMINE IN RAT VAS-DEFERENS, European journal of pharmacology, 265(3), 1994, pp. 125-132
In studies of electrically evoked isometric contractions of rat vas de
ferens, N-ethyl-maleimide (30 mu M) pretreatment significantly reduced
the prejunctional inhibitory potencies of xylazine and 5-hydroxytrypt
amine but failed to affect the potency of the alpha(1)-adrenoceptor ag
onist amidephrine. Phenoxybenzamine (1 mu M) or N-ethoxycarbonyl-2-eth
oxy-1,2-dihydroquinoline (EEDQ) (10 mu M) produced significant shifts
in the potency of xylazine and significantly reduced the maximum inhib
ition, but the combination of phenoxybenzamine or EEDQ and N-ethyl-mal
eimide (30 mu M) produced no further alteration in the effects of xyla
zine. In displacement studies, N-ethyl-maleimide displaced the binding
of [H-3]MK 912 -benzo[b]furo[2,3-a]quinazoline)-2,4'-pyrimidin-2' one
) to rat renal cortex membranes with a K-i of 466 +/- 133 mu M (n = 5)
, and so does not bind to alpha(2)-adrenoceptors in the concentration
range in which it affects prejunctional receptor mediated responses. T
his may suggest that N-ethyl-maleimide has actions other than inactiva
tion of G-proteins or that the irreversible alpha(2)-adrenoceptor anta
gonists phenoxybenzamine and EEDQ inactivate G-proteins sensitive to N
-ethyl-maleimide in concentrations at which they bind to alpha(2)-adre
noceptors.